Repligen Tops Q1 EPS by 20c; Lowers FY Outlook
- ByInvesting.com-
Repligen (NASDAQ:RGEN) reported Q1 EPS of $0.92, $0.20 better than the analyst estimate of $0.72. Revenue for the quarter came in at $206.4 million versus the consensus estimate of...